Amrita Krishnan, MD, hematologist-oncologist at the City of Hope Comprehensive Cancer Center, talks about what the future holds for managing people with multiple myeloma.

Multiple myeloma is a rare hematologic cancer characterized by the expansion of malignant plasma cells in the bone marrow that is associated with excessive production of monoclonal immunoglobulins in blood and urine.

Persons with multiple myeloma develop significant osteolytic bone lesions and immunodeficiencies.

Recently, there has been an explosion of research examining novel treatment options for new and relapsed multiple myeloma that is dramatically improving the outcomes for patients with this rare cancer.

To learn more about this and other rare cancers, visit


  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.